Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 4,772

Document Document Title
WO/2007/124610
The present invention concerns an antibody specific for human ALK (Anaplastic Lymphoma Kinase), in particular a scFv, a nucleic acid sequence encoding it, its production and its use as a pharmaceutical or for diagnostic purposes. Said an...  
WO/2007/125832
A new action of Helipyrone A is now found. As a useful application of Helipyrone A, the following agent is disclosed: a singlet oxygen scavenger, an anti-skin-aging agent, an anti-wrinkle agent, an anti-sagging agent, an agent for improv...  
WO/2007/124734
A compound of the formula A-R-X or pharmaceutically acceptable salts thereof can be used to manufacture a pharmaceutical preparation which serves to prevent or treat cancers, pathological sequelae of alcohol abuse, viral hepatitis, steat...  
WO/2007/124734
A compound of the formula A-R-X or pharmaceutically acceptable salts thereof can be used to manufacture a pharmaceutical preparation which serves to prevent or treat cancers, pathological sequelae of alcohol abuse, viral hepatitis, steat...  
WO/2007/123284
The present invention relates to an alpha lipoic acid capsule composition stabilized in aqueous phase, which can effectively prevent alpha lipoic acid from decomposing due to external environmental conditions, such as water, temperature,...  
WO/2007/119367
Tetrahydrobiopterin (BH4) to be used as a pharmaceutical has an excellent efficacy, therefore, expansion of use or application thereof is considered. However, because BH4 is expensive and unstable to oxidation, its application to other t...  
WO/2007/118276
The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or ot...  
WO/2007/118967
This invention relates to the use of cholest-4-in-3-one derivatives to obtain a cytoprotective medicine, excluding a neuroprotective medicine.  
WO/2007/116916
[PROBLEMS] To provide a liquid drug preparation for oral preparation by which the labor at drug-taking can be saved to thereby reduce patient burden and which enables safe drug-taking. [MEANS FOR SOLVING PROBLEMS] A liquid drug preparati...  
WO/2007/114791
The invention relates to a pharmaceutical composition containing 250 to 5000 millimoles per liter of lactate or lactic acid, 0.5 to 1.99 millimoles per liter of calcium and optionally 2 to 10 millimoles per liter of potassium. The invent...  
WO/2007/114461
Disclosed is a process for production of a composition having a carotenoid content of 80% or more, which comprises: extracting a culture of a microorganism, a condensation product of the culture or a dried product of the culture or the c...  
WO/2007/109893
The present invention relates to compositions and methods for reducing the cellular toxicity of a fume, particularly in relation to pulmonary inflammation, cytokine imbalance and lung disease. Plant extracts to be used with the compositi...  
WO/2007/109892
The present invention relates to compositions and methods for reducing the concentration of noxious substances in gases and smoke. Filters comprising plant extracts, such as parenchyma tissue extract and mesophyll cell extract, are also ...  
WO/2007/108438
A component capable of promoting glutathione production with enhanced effectiveness, and an external composition for use in promoting of glutathione production. Both γ-tocopherol and δ-tocopherol exhibit strikingly high glutathione pro...  
WO/2007/109804
The present invention relates to extracts of cinnamon species plant material prepared by supercritical CO2 extractions methods.  
WO/2007/105547
The invention provides methods for improving the absorbability and antioxidant ability of myricetin in the body. Either of the methods can be achieved by binding one or a plurality of glucosyl groups to the oxygen atom at the 3 or 3' pos...  
WO/2007/101365
The invention discloses a new flavane compound of formula (I) and its uses. The new flavane compound has antiinflammatory, antiallergic, antiviral and antioxidative effect, which is used to prepare antiinflammatory medicines or antialler...  
WO/2007/101349
A composition comprising Evodia rutaecarpia, green tea, black pepper and Cissus quandrangulans extracts, yohimbine and caffeine anhydrous for the purpose of reducing body fat mass and thus promoting weight loss The ingredients of the com...  
WO/2007/102735
The invention relates to the field of drug development against acute radiation injury caused by exposure to high-energy electromagnetic waves (X-rays, gamma rays) or particles (alpha particles, beta particles, neutrons). To date, there i...  
WO/2007/102572
A novel inhibitor for cellular aging which can effectively and fundamentally inhibit cellular aging. This inhibitor for cellular aging contains, as the active ingredient, a substance capable of inhibiting the expression of a gene encodin...  
WO/2007/101068
A method of treating and/or managing cystic fibrosis in a patient by administering an electrolyzed saline solution containing hypohalous acid. Preferably, the hypohalous acid is hypochlorous acid. Also provided is a method of treating an...  
WO/2007/099828
Nitrogenous heterocyclic derivatives represented by the general formula (I) which each bind specifically to NR1/NR2B receptor and are useful as NR2B receptor antagonists (particularly analgesic for cancer pain or neuroprotectant); pharma...  
WO/2007/095760
The invention includes novel compounds, including but not limited to formula A and formula B, and an improved delivery method. These compounds and methods are useful in preventing or treating diseases or conditions associated with or cau...  
WO/2007/096078
The invention relates to the use of resveratrol, a derivative, metabolite or analogue thereof for promoting the wellness state of a mammal or for changing gene expression profiles in older adult mammals towards conformity with expression...  
WO/2007/094498
[PROBLEMS] To provide a food composition effectively exerting an antioxidant effect in vivo, in particular, a food composition which is useful as a health food (including a food with health claims (a food for specified health uses and a ...  
WO/2007/092458
The present application discloses the use of compounds exhibiting both acetylcholinesterase (AchE) inhibition properties and σ-1 receptor agonist capacities for treating a mammal exposed to an exogenous neurotoxic agent, in particular n...  
WO/2007/086565
Disclosed is a growth hormone secretion regulator or anti-aging agent comprising aspartic acid and valine as active ingredients. Also disclosed is a pharmaceutical, food, nutritional supplement or feeding stuff comprising the growth horm...  
WO/2007/085679
The invention relates to the preparation of beta-carboline-type molecules from amino acids from natural products and foods, which act as reversible inhibitors of the enzyme monoaminooxidase (MAO). The reversible MAO inhibitors are used f...  
WO/2007/080560
The present invention concerns to the process of induction ofde novo synthesis of P-glycoprotein (P-gp) to be used as a treatment of xenobiotic-induced intoxications in mammals and, in particular, of paraquat (PQ)-induced intoxications (...  
WO/2007/080560
The present invention concerns to the process of induction ofde novo synthesis of P-glycoprotein (P-gp) to be used as a treatment of xenobiotic-induced intoxications in mammals and, in particular, of paraquat (PQ)-induced intoxications (...  
WO/2007/080787
The invention provides coenzyme Q10-containing compositions which are free from synthetic emulsifiers such as glycerol fatty acid esters, polyglycerol fatty acid esters, organic acid monoglycerides or sucrose fatty acid esters and which ...  
WO/2007/080201
The invention relates to the administration of low doses of IGF-I in ageing, owing to the neuroprotective, antioxidant and anabolic effects thereof and to the use of same in the preparation of products having a neuroprotective, antioxida...  
WO/2007/072869
Disclosed is an amorphous form of 3-(2-cyanophenyl)-5- (2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one.  
WO/2007/072868
Disclosed is a crystal of 3-(2-cyanophenyl)-5-(2-pyridyl)- 1-phenyl-1,2-dihydropyridin-2-one which is characterized by having a diffraction peak at a diffraction angle (2θ±0.2˚) of 15.4˚ in the powder X-ray diffraction pattern.  
WO/2007/073006
Disclosed is an inducer for the increasing of the content of a cytoprotective amino acid (methionine and/or homocysteine) in a living body, which comprises at least one component selected from the group consisting of carbon monooxide, pr...  
WO/2007/066458
A method for producing yeast for extraction of a lipid-soluble component according to the invention comprises a growth step in which yeast having a lipid-soluble component to be extracted is grown in such a manner that the medium pH decr...  
WO/2007/066744
It is intended to provide a food, a drink and a food/drink material having improved EGCg absorbability, and a method of producing the same by improving the absorbability of EGCg to be taken. The contents of caffeine and/or epigallocatech...  
WO/2007/055105
Disclosed is a novel anthocyanin compound. Specifically disclosed is an anthocyanin compound represented by the following chemical formula [1].  
WO/2007/052794
A compound or salt thereof which has antioxidant activity and is effective in the treatment of ischemic organ diseases including arteriosclerosis, heart infarction, and brain infarction, in the treatment of diseases caused by oxidative c...  
WO/2007/053526
It has now been discovered that certain cannabinoids specifically activate TRPV2 channel activity. Based on the discovery, novel compositions and methods for screening, identifying and characterizing compounds that increase or decrease t...  
WO/2007/050978
Disclosed herein are methods of treating infections, wounds, and exposure to particulate agents, comprising administering a heat shock protein (HSP) such as HSP70. The HSP may be uncomplexed to an antigenic peptide. Uncomplexed HSPs have...  
WO/2007/050978
Disclosed herein are methods of treating infections, wounds, and exposure to particulate agents, comprising administering a heat shock protein (HSP) such as HSP70. The HSP may be uncomplexed to an antigenic peptide. Uncomplexed HSPs have...  
WO/2007/045959
The present invention is directed to antioxidative and antiproliferative agents containing North American ginseng (proprietary extract HTlOOl) alone or in combination with Ginkgo biloba (GB), Saint John's Wort (SJW), ginkgolides, flavono...  
WO/2007/046729
This invention relates to biology and medicine and, in particular, can be used in medicine to make a pharmaceutical composition for targeted delivery of biologically active substances into mitochondria, driven by proton electro-chemical ...  
WO/2007/041940
Chinese medicinal compositions useful as anti-fatigue, anti-aging and gonadotrophic agent and processes for preparation thereof, active ingredients of which being prepared from Fructus lycii, Panax quinquefolium and Radices polygoni mult...  
WO/2007/039731
Use of xenon is described. Xenon is used as an organ and/or tissue and/or cell protectant in the manufacture of a pharmaceutical for the protection from injury of organs and/or tissue and/or cells that express HIF.  
WO/2007/034312
The present invention provides compounds of formula (I), or pharmaceutically acceptable salts or solvates thereof, methods for their preparation, methods for their use, and pharmaceutical formulations comprising them.  
WO/2007/034927
It is intended to find a novel medicinal application of sphingomyelin and to provide a preventive agent or a therapeutic agent for various diseases and a food and drink and feed containing the agent. A medicine which contains sphingomyel...  
WO/2007/034312
The present invention provides compounds of formula (I), or pharmaceutically acceptable salts or solvates thereof, methods for their preparation, methods for their use, and pharmaceutical formulations comprising them.  
WO/2007/029889
Disclosed is a myocardial cell-protecting agent containing a compound represented by the formula (Ia) below, a pharmaceutically acceptable salt thereof, or a solvate of either of them.  

Matches 601 - 650 out of 4,772